Moss Professor of Diabetes at the University of Virginia School of Medicine and former chief of UVA Healths Division of Endocrinology and Metabolism
Federal law prohibits Medicare from covering drugs solely for weight loss, meaning GLP-1s are only reimbursed under Part D for other approved indications, like type 2 diabetes, cardiovascular risk reduction, MASH, or sleep apnea
6-Month Results: Improved confidence, better appetite control, and increased energy levels
PT-141 and melanotan II activate melanocortin-4 receptors (MC4R) in the hypothalamus, specifically the paraventricular nucleus and medial preoptic area
When a companys stock soars because its drug is changing the game, theres always someone looking for a way to push it back down